ThePigSite.com - news, features, articles and disease information for the swine industry

News

Scientist ‘pops the hood’ on US pork industry’s newest vaccine for PCV2

29 November 2018

Poultry Health Today

What is “cell-mediated immunity” and how does it affect vaccine performance? Are two PCV2 genotypes necessarily better than one? And what does a monster from Greek mythology have to do with building a better vaccine?

 

In an interview with Pig Health Today, veterinary immunologist Meggan Bandrick, DVM, PhD, popped the hood on the US pork industry’s newest PCV2 vaccine and answered these questions in practical terms.

Watch the full interview or each part separately:

Full interview: What’s under the hood? Veterinary immunologist explains merits of new PCV2 vaccine

Part 1: Cell-mediated immunity critical to vaccine performance

Part 2: Why two PCV2 genotypes are better than one

Part 3: Chimeric vaccines combine strengths of each antigen to provide better coverage



Share This

News By

Related News

More News

Our Sponsors

Partners


Seasonal Picks

Animal Welfare Science, Husbandry and Ethics: The Evolving Story of Our Relationship with Farm Animals - 5m Books